Sao Tome and Principe vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB
Sao Tome and Principe
100.0%
in 2022
United Arab Emirates
100.0%
in 2022
Sao Tome and Principe rank
1st
United Arab Emirates rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Sao Tome and Principe
- United Arab Emirates
How they compare
Sao Tome and Principe currently reports 100.0% against 100.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 2 times across 7 shared years of data; in 2011 it was United Arab Emirates ahead.
Sao Tome and Principe ranks 1st and United Arab Emirates ranks 1st of 163 countries.
Sao Tome and Principe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sao Tome and Principe | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76.7% | 25.0% | 51.7% | Sao Tome and Principe |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Sao Tome and Principe or United Arab Emirates?
- Sao Tome and Principe, at 100.0% against 100.0% in United Arab Emirates as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Sao Tome and Principe and United Arab Emirates?
- 0.0%, with Sao Tome and Principe ahead.
- How many years of comparable data are there for Sao Tome and Principe and United Arab Emirates?
- 7 years are reported by both, from 2011 to 2022.
- How do Sao Tome and Principe and United Arab Emirates rank globally for treatment success rate for patients treated for mdr-tb?
- Sao Tome and Principe ranks 1st and United Arab Emirates ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.